Home > Balance Sheet > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Deferred Tax Assets / Liabilities ₹4,972 Cr₹235 Cr₹101 Cr₹-142 Cr₹-300 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?

The latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS is ₹4,972 Cr based on Mar2026 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2026₹4,972 Cr
Mar2025₹235 Cr
Mar2024₹101 Cr
Mar2023₹-142 Cr
Mar2022₹-300 Cr

How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2026 ₹4,972 Cr
2,019.53
Mar2025 ₹235 Cr
132.43
Mar2024 ₹101 Cr
Positive
Mar2023 ₹-142 Cr
Negative
Mar2022 ₹-300 Cr -

Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹184,125.0 Cr -1.5% -3.3% 35.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics
MANKIND PHARMA ₹99,945.0 Cr -0.7% -4.9% -4.9% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-1.5%

-3.3%

35.6%

SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses